Skip to content
healthcare.dev

KALI MURIATICUM

NDC 15631-0251, KALI MURIATICUM, pellet, from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc.

Product NDC
15631-0251
Status
Listed
Labeler
Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/15631-0251 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CHLORIDE1 [hp_X]/1

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
15631-0251-015631025100100 PELLET in 1 PACKAGE (15631-0251-0)
15631-0251-115631025101200 PELLET in 1 PACKAGE (15631-0251-1)
15631-0251-215631025102400 PELLET in 1 PACKAGE (15631-0251-2)
15631-0251-315631025103750 PELLET in 1 PACKAGE (15631-0251-3)
15631-0251-4156310251042500 PELLET in 1 PACKAGE (15631-0251-4)
15631-0251-51563102510512500 PELLET in 1 PACKAGE (15631-0251-5)
15631-0251-615631025106500 PELLET in 1 PACKAGE (15631-0251-6)
15631-0251-7156310251071000 PELLET in 1 PACKAGE (15631-0251-7)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 15631-0251 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/15631-0251 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 15631-0251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.